Skip to main content

MoneyWorks4Me

Parmax Pharma informs about revised standalone financial results

29 Mar 2017 Evaluate

Parmax Pharma has informed about Revised Standalone Financial Results for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..